12
Participants
Start Date
August 27, 2024
Primary Completion Date
August 15, 2026
Study Completion Date
January 31, 2027
midomafetamine (MDMA)-Assisted Therapy
This treatment consists 3 Preparation sessions followed by 3 Experimental sessions at 4-week intervals; after each Experimental session, 3 weekly Integration sessions will be conducted. For the first Experimental Session, the dose of MDMA is 80 mg; for the second and third Experimental Sessions, the dose of MDMA is 120 mg. For all three Experimental sessions, a supplemental dose of 50% of the initial dose will be available. The Preparation, Experimental, and Integration Sessions will involve psychotherapy developed specifically for this trial and population.
RECRUITING
University of Washington, Seattle
University of Washington
OTHER